Biocryst Pharmaceuticals, Inc.

NC · United States · Reporting entity ID 100000136528

Total reported 2019–2025

$15.8M

#376 of 2,960 reporting companies — 0% of all reported industry payments

$2.78M in general payments across 2,434 records, plus $13.1M in research funding across 852 records.

How it breaks down

General payments $2,781,251

Research funding $13,060,907

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.